Skip to content

Three Quick Facts: Abingdon Health, Dignity and Vast Resources


Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Abingdon Health interims show transition away from COVID testing complete

Interim results from Abingdon Health LON:ABDX note that the company has now completed its transition away from COVID testing. Revenues for the last six months came in a £1.1m, down from the £1.7m a year earlier but expectations are for a significant improvement in the second half, with FY income of £2.8m anticipated. Gross margins have improved slightly and the company had £4.4m cash at the year end, a number that is forecast as being £3.7m today. The board expects to be cashflow positive in FY’24.

#2. Dignity market share grows but losses mount

Funeral operator Dignity LON:DTY saw revenues shrink once again, falling 13% for the full year to 31st December. That has taken a toll on underlying profits which declined from £56m to less than £18m. Management note that proactive changes in pricing, a move towards cheaper funerals and cost pressures – some of which it is having to absorb – continue to weigh on performance, despite a modest uptick in share of market.

#3. Vast Resources update on release of diamonds

There’s a short update out from Vast Resources LON:VAST confirming that the processes for the release of diamonds which were being held in the custody of the Reserve Bank of Zimbabwe are underway. A further statement regarding physical receipt of the diamonds will be made on finalisation.

Looking for great investing ideas? Sign up to our free newsletter.

Join us on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top